logo

For the Inventor, By the Inventor

Zhejiang, China

Tyk Medicines Inc.

Calculating rank
USPTO Granted Patents = 5


Forward Citations = 0

Loading Chart...
Loading Chart...

7 inventors (with patents filed for the assignee):

goldMedal Yusheng Wu (5 out of 5 patents)

silverMedal Apeng Liang (5 out of 5 patents)

bronzeMedal Chengshan Niu (5 out of 5 patents)

4.  Jun Li (4 out of 20 patents)

5.  Maolin Zheng (2 out of 2 patents)

6.  Yang Geng (1 out of 1 patent)

7.  Zhongwei Guo (1 out of 1 patent)


5 patents:

1. 12629358 - Compound used as RET kinase inhibitor and application thereof (2026-05-19),
2. 12545681 - Compound used as RET kinase inhibitor and application thereof (2026-02-10),
3. 12509441 - Compounds used as kinase inhibitors and application thereof (2025-12-30),
4. 12435089 - 3-oxadiazolyl substituted pyrazolo[1,5,a]pyrimidines for ROS1, NTRK, and ALK mediated diseases (2025-10-07),
5. 10882845 - Crystal form of deuterated AZD9291, preparation method therefor, and use thereof (2021-01-05),
logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

5 Patents

#131 in Zhejiang

#5,265 in China

Zhejiang, CN
Zhejiang, China

Tyk Medicines Inc.

Forward Citations = 0

7 inventors:

goldMedal Yusheng Wu (5 out of 5 patents)

silverMedal Apeng Liang (5 out of 5 patents)

bronzeMedal Chengshan Niu (5 out of 5 patents)

4.  Jun Li (4 out of 20 patents)

5.  Maolin Zheng (2 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Tyk Medicines Inc.. Retrieved from https://idiyas.com/company/tyk-medicines

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…